Story perspectives

Supreme Court Orders Pharma Marketing Committee by 2026

By Drooid · Oct 8, 2026, 10:14 AM UTC · How we work

Summary

Story summary

India’s Supreme Court ordered the Union to establish a pharma-marketing committee on October 8, 2026.
Justices Vikram Nath and Sandeep Mehta mandated a compliance report by January 29, 2027.
FMRAI filed the petition alleging firms give doctors gifts, trips and other perks.
The government says the 2024 Uniform Code works but lacks statutory force.
A 2022 panel led by Dr V.K. Paul recommended strengthening the voluntary code rather than creating statutory law.

History

Historical Context

The United States enacted the Physician Payments Sunshine Act in 2010, mandating public disclosure of pharmaceutical gifts to physicians and aimed to reduce conflicts of interest. The Department of Health and Human Services, via CMS, recorded $10 billion in industry payments during the 2013 reporting year and required quarterly updates. India’s Supreme Court now mirrors this approach, ordering a pharma-marketing committee to curb gifts, echoing the U.S. transparency push and similar state-level statutes. If enforced, the mandate could pressure Indian lawmakers to grant statutory force to the 2024 Uniform Code, reshaping industry practices and could spur further judicial scrutiny.

1 of 2

Story summary

India’s Supreme Court ordered the Union to establish a pharma-marketing committee on October 8, 2026.
Justices Vikram Nath and Sandeep Mehta mandated a compliance report by January 29, 2027.
FMRAI filed the petition alleging firms give doctors gifts, trips and other perks.
The government says the 2024 Uniform Code works but lacks statutory force.
A 2022 panel led by Dr V.K. Paul recommended strengthening the voluntary code rather than creating statutory law.

1 / 2